Search details
1.
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.
Blood Adv
; 7(7): 1092-1102, 2023 04 11.
Article
in English
| MEDLINE | ID: mdl-36508268
Results
1 -
1
de 1
1
Next >
>>